|
2017 Journal Article Preclinical mammalian safety studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)Wagner, Michael J., Mitra, Rahul, McArthur, Mark J., Baze, Wallace, Barnhart, Kirstin, Wu, Sherry Y., Rodriguez-Aguayo, Cristian, Zhang, Xinna, Coleman, Robert L., Lopez-Berestein, Gabriel and Sood, Anil K. (2017). Preclinical mammalian safety studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Molecular Cancer Therapeutics, 16 (6), 1114-1123. doi: 10.1158/1535-7163.MCT-16-0541 |
|
2017 Journal Article HSP70 inhibition synergistically enhances the effects of magnetic fluid hyperthermia in ovarian cancerCourt, Karem A., Hatakeyama, Hiroto, Wu, Sherry Y., Lingegowda, Mangala S., Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Ju-Seog, Lee, Rinaldi, Carlos, Juan, Eduardo J., Sood, Anil K. and Torres-Lugo, Madeline (2017). HSP70 inhibition synergistically enhances the effects of magnetic fluid hyperthermia in ovarian cancer. Molecular Cancer Therapeutics, 16 (5), 966-976. doi: 10.1158/1535-7163.MCT-16-0519 |
|
2016 Journal Article Role of CTGF in sensitivity to hyperthermia in ovarian and uterine cancersHatakeyama, Hiroto, Wu, Sherry Y., Lyons, Yasmin A., Pradeep, Sunila, Wang, Wanqin, Huang, Qian, Court, Karem A., Liu, Tao, Nie, Song, Rodriguez-Aguayo, Cristian, Shen, Fangrong, Huang, Yan, Hisamatsu, Takeshi, Mitamura, Takashi, Jennings, Nicholas, Shim, Jeajun, Dorniak, Piotr L., Mangala, Lingegowda S., Petrillo, Marco, Petyuk, Vladislav A., Schepmoes, Athena A., Shukla, Anil K., Torres-Lugo, Madeline, Lee, Ju-Seog, Rodland, Karin D., Fagotti, Anna, Lopez-Berestein, Gabriel, Li, Chun and Sood, Anil K. (2016). Role of CTGF in sensitivity to hyperthermia in ovarian and uterine cancers. Cell Reports, 17 (6), 1621-1631. doi: 10.1016/j.celrep.2016.10.020 |
|
2016 Journal Article BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancerYokoyama, Yuhki, Zhu, Hengrui, Lee, Jeong Heon, Kossenkov, Andrew V., Wu, Sherry Y., Wickramasinghe, Jayamanna M., Yin, Xiangfan, Palozola, Katherine C., Gardini, Alessandro, Showe, Louise C., Zaret, Kenneth S., Liu, Qin, Speicher, David, Conejo-Garcia, Jose R., Bradner, James E., Zhang, Zhiguo, Sood, Anil K., Ordog, Tamas, Bitler, Benjamin G. and Zhang, Rugang (2016). BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer. Cancer Research, 76 (21), 6320-6330. doi: 10.1158/0008-5472.CAN-16-0854 |
|
2016 Journal Article Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progressionRupaimoole, R., Ivan, C., Yang, D., Gharpure, K. M., Wu, S. Y., Pecot, C. V., Previs, R. A., Nagaraja, A. S., Armaiz-Pena, G. N., McGuire, M., Pradeep, S., Mangala, L. S., Rodriguez-Aguayo, C., Huang, L., Bar-Eli, M., Zhang, W., Lopez-Berestein, G., Calin, G. A. and Sood, A. K. (2016). Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene, 35 (33), 4312-4320. doi: 10.1038/onc.2015.492 |
|
2016 Journal Article Role of increased n-acetylaspartate Levels in cancerZand, Behrouz, Previs, Rebecca A., Zacharias, Niki M., Rupaimoole, Rajesha, Mitamura, Takashi, Nagaraja, Archana Sidalaghatta, Guindani, Michele, Dalton, Heather J., Yang, Lifeng, Baddour, Joelle, Achreja, Abhinav, Hu, Wei, Pecot, Chad V., Ivan, Cristina, Wu, Sherry Y., McCullough, Christopher R., Gharpure, Kshipra M., Shoshan, Einav, Pradeep, Sunila, Mangala, Lingegowda S., Rodriguez-Aguayo, Cristian, Wang, Ying, Nick, Alpa M., Davies, Michael A., Armaiz-Pena, Guillermo, Liu, Jinsong, Lutgendorf, Susan K., Baggerly, Keith A., Bar Eli, Menashe ... Sood, Anil K. (2016). Role of increased n-acetylaspartate Levels in cancer. JNCI-Journal of the National Cancer Institute, 108 (6), djv426. doi: 10.1093/jnci/djv426 |
|
2016 Journal Article FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawalHaemmerle, Monika, Bottsford-Miller, Justin, Pradeep, Sunila, Taylor, Morgan L., Choi, Hyun-Jin, Hansen, Jean M., Dalton, Heather J., Stone, Rebecca L., Cho, Min Soon, Nick, Alpa M., Nagaraja, Archana S., Gutschner, Tony, Gharpure, Kshipra M., Mangala, Lingegowda S., Rupaimoole, Rajesha, Han, Hee Dong, Zand, Behrouz, Armaiz-Pena, Guillermo N., Wu, Sherry Y., Pecot, Chad V., Burns, Alan R., Lopez-Berestein, Gabriel, Afshar-Kharghan, Vahid and Sood, Anil K. (2016). FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. Journal of Clinical Investigation, 126 (5), 1885-1896. doi: 10.1172/JCI85086 |
|
2016 Journal Article A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancerWu, Sherry Y., Rupaimoole, Rajesha, Shen, Fangrong, Pradeep, Sunila, Pecot, Chad V., Ivan, Cristina, Nagaraja, Archana S., Gharpure, Kshipra M., Pham, Elizabeth, Hatakeyama, Hiroto, McGuire, Michael H., Haemmerle, Monika, Vidal-Anaya, Viviana, Olsen, Courtney, Rodriguez-Aguayo, Cristian, Filant, Justyna, Ehsanipour, Ehsan A., Herbrich, Shelley M., Maiti, Sourindra N., Huang, Li, Kim, Ji Hoon, Zhang, Xinna, Han, Hee-Dong, Armaiz-Pena, Guillermo N., Seviour, Elena G., Tucker, Sue, Zhang, Min, Yang, Da, Cooper, Laurence J. N. ... Sood, Anil K. (2016). A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. Nature Communications, 7 (1) 11169. doi: 10.1038/ncomms11169 |
|
2015 Journal Article Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysisRupaimoole, Rajesha, Lee, Jaehyuk, Haemmerle, Monika, Ling, Hui, Previs, Rebecca A., Pradeep, Sunila, Wu, Sherry Y., Ivan, Cristina, Ferracin, Manuela, Dennison, Jennifer B., Millward, Niki M. Zacharias, Nagaraja, Archana S., Gharpure, Kshipra M., McGuire, Michael, Sam, Nidhin, Armaiz-Pena, Guillermo N., Sadaoui, Nouara C., Rodriguez-Aguayo, Cristian, Calin, George A., Drapkin, Ronny I., Kovacs, Jeffery, Mills, Gordon B., Zhang, Wei, Lopez-Berestein, Gabriel, Bhattacharya, Pratip K. and Sood, Anil K. (2015). Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis. Cell Reports, 13 (11), 2395-2402. doi: 10.1016/j.celrep.2015.11.047 |
|
2015 Journal Article Advances and challenges of liposome assisted drug deliverySercombe, Lisa, Veerati, Tejaswi, Moheimani, Fatemeh, Wu, Sherry Y., Sood, Anil K. and Hua, Susan (2015). Advances and challenges of liposome assisted drug delivery. Frontiers in Pharmacology, 6. doi: 10.3389/fphar.2015.00286 |
|
2015 Journal Article Erythropoietin stimulates tumor growth via EphB4Pradeep, Sunila, Huang, Jie, Mora, Edna M., Nick, Alpa M., Cho, Min Soon, Wu, Sherry Y., Noh, Kyunghee, Pecot, Chad V., Rupaimoole, Rajesha, Stein, Martin A., Brock, Stephan, Wen, Yunfei, Xiong, Chiyi, Gharpure, Kshipra, Hansen, Jean M., Nagaraja, Archana S., Previs, Rebecca A., Vivas-Mejia, Pablo, Han, Hee Dong, Hu, Wei, Mangala, Lingegowda S., Zand, Behrouz, Stagg, Loren J., Ladbury, John E., Ozpolat, Bulent, Alpay, S. Neslihan, Nishimura, Masato, Stone, Rebecca L., Matsuo, Koji ... Sood, Anil K. (2015). Erythropoietin stimulates tumor growth via EphB4. Cancer Cell, 28 (5), 610-622. doi: 10.1016/j.ccell.2015.09.008 |
|
2015 Journal Article Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagyGaur, Sanchaika, Wen, Yunfei, Song, Jian H., Parikh, Nila U., Mangala, Lingegowda S., Blessing, Alicia M., Ivan, Cristina, Wu, Sherry Y., Varkaris, Andreas, Shi, Yan, Lopez-Berestein, Gabriel, Frigo, Daniel E., Sood, Anil K. and Gallick, Gary E. (2015). Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Oncotarget, 6 (30), 29161-29177. doi: 10.18632/oncotarget.4971 |
|
2015 Journal Article XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5AMiyake, Takahito, Pradeep, Sunila, Wu, Sherry Y., Rupaimoole, Rajesha, Zand, Behrouz, Wen, Yunfei, Gharpure, Kshipra M., Nagaraja, Archana S., Hu, Wei, Cho, Min Soon, Dalton, Heather J., Previs, Rebecca A., Taylor, Morgan L., Hisamatsu, Takeshi, Kang, Yu, Liu, Tao, Shacham, Sharon, McCauley, Dilara, Hawke, David H., Wiktorowicz, John E., Coleman, Robert L. and Sood, Anil K. (2015). XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A. Clinical Cancer Research, 21 (14), 3286-3297. doi: 10.1158/1078-0432.CCR-14-1953 |
|
2015 Journal Article Nanotechnology: future of oncotherapyGharpure, Kshipra M., Wu, Sherry Y., Li, Chun, Lopez-Berestein, Gabriel and Sood, Anil K. (2015). Nanotechnology: future of oncotherapy. Clinical Cancer Research, 21 (14), 3121-3130. doi: 10.1158/1078-0432.CCR-14-1189 |
|
2014 Journal Article Therapeutic silencing of KRAS using systemically delivered siRNAsPecot, Chad V., Wu, Sherry Y., Bellister, Seth, Filant, Justyna, Rupaimoole, Rajesha, Hisamatsu, Takeshi, Bhattacharya, Rajat, Maharaj, Anshumaan, Azam, Salma, Rodriguez-Aguayo, Cristian, Nagaraja, Archana S., Morelli, Maria Pia, Gharpure, Kshipra M., Waugh, Trent A., Gonzalez-Villasana, Vianey, Zand, Behrouz, Dalton, Heather J., Kopetz, Scott, Lopez-Berestein, Gabriel, Ellis, Lee M. and Sood, Anil K. (2014). Therapeutic silencing of KRAS using systemically delivered siRNAs. Molecular Cancer Therapeutics, 13 (12), 2876-2885. doi: 10.1158/1535-7163.MCT-14-0074 |
|
2014 Journal Article Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRupaimoole, Rajesha, Wu, Sherry Y., Pradeep, Sunila, Ivan, Cristina, Pecot, Chad V., Gharpure, Kshipra M., Nagaraja, Archana S., Armaiz-Pena, Guillermo N., McGuire, Michael, Zand, Behrouz, Dalton, Heather J., Filant, Justyna, Miller, Justin Bottsford, Lu, Chunhua, Sadaoui, Nouara C., Mangala, Lingegowda S., Taylor, Morgan, van den Beucken, Twan, Koch, Elizabeth, Rodriguez-Aguayo, Cristian, Huang, Li, Bar-Eli, Menashe, Wouters, Bradly G., Radovich, Milan, Ivan, Mircea, Calin, George A., Zhang, Wei, Lopez-Berestein, Gabriel and Sood, Anil K. (2014). Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nature Communications, 5 (5202) 5202. doi: 10.1038/ncomms6202 |
|
2014 Journal Article Hematogenous metastasis of ovarian cancer: rethinking mode of spreadPradeep, Sunila, Kim, Seung W., Wu, Sherry Y., Nishimura, Masato, Chaluvally-Raghavan, Pradeep, Miyake, Takahito, Pecot, Chad V., Kim, Sun-Jin, Choi, Hyun Jin, Bischoff, Farideh Z., Mayer, Julie Ann, Huang, Li, Nick, Alpa M., Hall, Carolyn S., Rodriguez-Aguayo, Cristian, Zand, Behrouz, Dalton, Heather J., Arumugam, Thiruvengadam, Lee, Ho Jeong, Han, Hee Dong, Cho, Min Soon, Rupaimoole, Rajesha, Mangala, Lingegowda S., Sehgal, Vasudha, Oh, Sang Cheul, Liu, Jinsong, Lee, Ju-Seog, Coleman, Robert L., Ram, Prahlad ... Sood, Anil K. (2014). Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell, 26 (1), 77-91. doi: 10.1016/j.ccr.2014.05.002 |
|
2014 Journal Article Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancerGharpure, Kshipra M., Chu, Kevin S., Bowerman, Charles J., Miyake, Takahito, Pradeep, Sunila, Mangala, Selanere L., Han, Hee-Dong, Rupaimoole, Rajesha, Armaiz-Pena, Guillermo N., Rahhal, Tojan B., Wu, Sherry Y., Luft, J. Christopher, Napier, Mary E., Lopez-Berestein, Gabriel, DeSimone, Joseph M. and Sood, Anil K. (2014). Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer. Molecular Cancer Therapeutics, 13 (7), 1750-1757. doi: 10.1158/1535-7163.MCT-13-0930 |
|
2014 Journal Article Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancerTucker, Susan L., Gharpure, Kshipra, Herbrich, Shelley M., Unruh, Anna K., Nick, Alpa M., Crane, Erin K., Coleman, Robert L., Guenthoer, Jamie, Dalton, Heather J., Wu, Sherry Y., Rupaimoole, Rajesha, Lopez-Berestein, Gabriel, Ozpolat, Bulent, Ivan, Cristina, Hu, Wei, Baggerly, Keith A. and Sood, Anil K. (2014). Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clinical Cancer Research, 20 (12), 3280-3288. doi: 10.1158/1078-0432.CCR-14-0445 |
|
2014 Journal Article Notch3 pathway alterations in ovarian cancerHu, Wei, Liu, Tao, Ivan, Cristina, Sun, Yunjie, Huang, Jie, Mangala, Lingegowda S., Miyake, Takahito, Dalton, Heather J., Pradeep, Sunila, Rupaimoole, Rajesh, Previs, Rebecca A., Han, Hee Dong, Bottsford-Miller, Justin, Zand, Behrouz, Kang, Yu, Pecot, Chad V., Nick, Alpa M., Wu, Sherry Y., Lee, Ju-Seog, Sehgal, Vasudha, Ram, Prahlad, Liu, Jinsong, Tucker, Susan L., Lopez-Berestein, Gabriel, Baggerly, Keith A., Coleman, Robert L. and Sood, Anil K. (2014). Notch3 pathway alterations in ovarian cancer. Cancer Research, 74 (12), 3282-3293. doi: 10.1158/0008-5472.CAN-13-2066 |
